Randomized Phase III Study Comparing Paclitaxel-Bleomycin, Etoposide, and Cisplatin (BEP) to Standard BEP in Intermediate-Prognosis Germ-Cell Cancer: Intergroup Study EORTC 30983
- Publication date
- 1 January 2012
- Publisher
- 'American Society of Clinical Oncology (ASCO)'